High Resolution Anoscopy Overview. Naomi Jay, RN, NP, PhD University of California San Francisco
|
|
- Teresa Turner
- 5 years ago
- Views:
Transcription
1 High Resolution Anoscopy Overview Naomi Jay, RN, NP, PhD University of California San Francisco
2 Disclosures No Disclosures
3 Definition of HRA Examination of the anus, anal canal and perianus using a colposcope with 5% acetic acid and Lugol s solution.
4 Basic Principles Office-based procedure Adapted from gynecologic colposcopy. Validated for anal canal. Similar terminology and descriptors. may be unfamiliar to non-gyn providers. Comparable to vaginal and vulvar colposcopy. Clinicians familiar with cervical colposcopy may be surprised by the difficult transition.
5
6
7
8
9
10 Anal SCJ & AnTZ Original vs. current SCJ less relevant. TZ features less common, therefore more difficult to appreciate. SCJ more subtle, difficult to see in entirety requires more manipulation & acetic acid. Larger area of metaplastic changes overlying columnar epithelium compared to endocervix. Most lesions found in the AnTZ.
11
12
13
14
15
16
17
18
19
20
21 Atypical Metaplasia Atypical metaplasia may indicate the presence of HSIL. Radiate over distal rectum from SCJ. Thin, may wipe off. Features to look for indicating potential lesions: Atypical clustered glands (ACG) Lacy metaplastic borders (LM) Epithelial Honeycombing (EH)
22
23
24
25
26
27
28 Lugol s Staining. More utility in anus compared to cervix. Adjunctive to help define borders, distinguish between possible LSIL/HSIL. Most HSIL will be Lugol s negative LSIL may be Lugol s partial or negative Applied focally with small cotton swabs to better define an acetowhite lesion. NOT a short cut to determine presence or absence of lesions, acetic acid is used first and is applied frequently.
29 Anal vs. Cervical Characteristics Punctation & Mosaic rarely fine mostly coarse. Mosaic pattern mostly associated with HSIL. Atypical vessels may be HSIL or cancer Epithelial honeycombing & lacy metaplasia unique anal descriptors.
30 Typical LSIL Characteristics AWE, raised, papillary, warty vessels, Lugol s partialcomplete. AWE, shiny, Flat, punctation or none, Lugol s partialnegative. Indistinct AWE, micropapillary changes with Lugol s partial. Biopsy to establish diagnosis!
31
32 Typical HSIL Characteristics AWE, thickened, grey, flat tone. Smooth, sharp or indistinct border. Flat or slightly raised smooth thickening. Coarse punctation and mosaic pattern. Lugol s negative. Shallow ulcerations, friability. Example: AWE, grey, flat, distinct with CP and CM, LN. Biopsy to establish diagnosis!
33
34 HRA Signs of Invasive Cancer AWE may or may not be evident due to bleeding. Very coarse punctation and mosaic pattern. Atypical, non-branching, bizarre patterns, dilated vessels. Friable lesions. Denuded epithelium, fissures, or ulcerations. Coarse mosaic pattern appearing on keratinized mucosa.
35
36
37
38
39 Differences Higher magnification compared to cervical. Requires liberal application and re-application of acetic acid. Adjunctive use of Lugol s staining to highlight acetic acid findings. Physically more demanding. Requires adequate time ~ 15 minutes for experienced clinician.
40 Equipment If you can t see well, you can t find lesions. HRA requires higher magnification compared to cervical colposcopy and it needs to be used. Colposcope with better and higher magnification range. Non-ocular scopes do not work well
41
42
43 Got HRA? Field is relatively young with growing demand for services. Discuss with colleagues providing HRA. Rewarding, challenging sometimes a difficult transition. With practice, expertise is certainly possible. Consider taking the HRA Course July 2016 in Providence!
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73 Understanding the Practice of HRA What Providers Need to Know About Managing Anal HSIL: Lessons Learned from Referrals J. Michael Berry-Lawhorn, MD Clinical Professor of Medicine University of California San Francisco Associate Director HPV-Related Clinical Studies
74 Disclosures I have no significant financial relationships to disclose that would pose a potential conflict of interest. Non-FDA-Approved There are NO FDA-approved treatments for anal HSIL.
75 Introduction Clinical scenarios faced frequently by providers who care for women Caveats about HRA Case-based demonstration of clinical points indicating importance, pitfalls, and challenges of HRA in managing anal neoplasia in women Conclusions
76 Now what do I do??? You don't perform HRA, but she insisted on having anal cytology and it shows HSIL Your patient over 50 just had her colonoscopy and was found to have anal condyloma You are treating a woman with extensive vulvar HSIL, you realize the lesions extend posteriorly and surround the anus Your patient has been diagnosed serendipitously with anal HSIL or SISCCA and is calling you for advice ALL of these women need high-resolution anoscopy or HRA!!!
77 Who Manages Anal HSIL? Typically referrals are made to general surgery, dermatology, oncology, gynecologic oncology, or colorectal surgery Currently very few of these providers have been trained in HRA A few providers have never heard of HRA Some have attended a 2-4 hour lecture and decided that HRA can be easily performed or they are very experienced colposcopists No matter what the experience level, there is no substitute for rigorous training and experience performing HRA
78 Why aren t there more HRA Providers Relatively new procedure, first public HRA course offered by ASCCP in 2005 Steep learning curve, even for those with colposcopy experience Getting good requires seeing high volume of patients at high-risk.. Minimum of 1-2 days per week No evidence yet that treating HSIL prevents cancer However, we and many others believe since HSIL is a precancerous lesion that it should be treated, when found
79 Initial HRA Results after Referral from Anal Surgeons Biopsy-proven HSIL 35 of 47 (74%) Squamous cell carcinoma 8 of 47 (17%) No lesions 4 of 47 ( 9%) (2 developed HSIL within 8 months) Presented at the 2012 ASCCP Biennial Meeting: Prevalence of High-Grade Anal Neoplasia after Referral from Anal Surgeons
80 Lessons Learned from Referrals
81 Case 1 54 YO woman with cervical HSIL diagnosed in 1994 treated with cryotherapy, subsequent normal cytology She works at a hospital clinical laboratory, learned about the association between HPV and anal cancer Requested anal cytology on 1/5/2007 which was negative but positive for HPV-16. Regular anoscopy normal and negative anal cytology until 3/30/3015 when anal cytology showed HSIL Referred for high resolution anoscopy (HRA).
82
83
84 Teaching Points Regular anoscopy has a limited role in managing positive HRHPV results Repeated cytology may be useful in following women serially Unlike cervical colposcopy, metaplasia should be biopsied in the anus to exclude HSIL HRA maximizes detection of HSIL
85 Case 2 60 YO woman s/p cryotherapy 40 years ago for abnormal Pap Diagnosed with Rheumatoid Arthritis at age 28 and has been maintained on etanercept (Enbrel) since 2000 In 2010 she had colonoscopy and condyloma biopsied: HSIL/AIN 3 Referred to colorectal surgeon for excision: normal hemorrhoid without dysplasia Referred for HRA
86
87
88
89
90
91
92
93 Teaching Points Well-trained colorectal surgeons who do not perform HRA may miss extensive HSIL Office-based treatment can successfully eradicate extensive HSIL
94 Case 3 29 YO HIV-negative woman, smoker c/o 2 year "vaginal rash", no relief with any OTC, resorted to using triamcinolone QID. Unable to have sex due to pain. Diagnosed with extensive vulvar HSIL/VIN 3. At UCSF lesions noted to extend to perineum. Anal cytology HSIL/severe dysplasia Referred for HRA, initial exam too painful
95
96
97
98
99
100
101 Teaching Points Women with extensive vulvar lesions that extend to the perineum are highly likely to have anal canal and perianal HSIL. Once trained, an intra-anal block can easily be done when necessary. Extensive HSIL lesions can be subtle in appearance and require good light, lots of acetic acid, and high magnification.
102 Case 4 63 YO woman with no prior history of HPV-related LGTN referred for HRA because of persistent PA HSIL. Untreated hepatitis C, subsequently treated. Initially treated with 5FU (regimen not specified) with persistent HSIL followed by WLE with advancement flap for closure in September Recurrent PA HSIL in November Referred for HRA on February 13, 2015.
103
104
105
106
107
108
109 Teaching Points You must excise lesions that are clinically suspicious for cancer, unless HRA-directed biopsies show cancer. WLE and flaps are ALMOST NEVER needed to treat extensive HSIL. Suturing should be minimized unless needed for hemostasis; anecdotally associated with progression to cancer.
110
111
112
113
114
115
116
117
118
119 Teaching Points In order to successfully eradicate extensive HSIL, you must be persistent and appropriately aggressive. Patients need very close follow-up and must understand the process in order to be motivated. USE the colposcope when treating PA and possibly vulvar lesions to enhance identification of HSIL.
120
121
122
123 Teaching Point You must define HSIL borders using high magnification and acetic acid to maximize treatment outcome and minimize recurrence.
124
125
126
127
128 Teaching Points Although lesions are superficial, after initial burn, you must debride until you are sure that all abnormal vessels/epithelium have been ablated down to the submucosa. Then, burn the base of the lesion lightly.
129 Case 5 68 YO woman with a remote history of cryotherapy for cervical dysplasia +FOBT led to colonoscopy with anorectal mass Excised SCCA with 0.1 mm margin Referred to see if appropriate for conservative management, local tumor board thought CMT might be excessive and surgeon was confident that cancer had been removed
130
131
132
133
134 Teaching Points You must learn how to perform careful, thorough DARE. ALWAYS biopsy abnormal appearing, subepithelial tissue and if worried about cancer, biopsy deep base of lesion after initial biopsy. Suturing should be minimized unless needed for hemostasis; anecdotally associated with progression to cancer.
135 Conclusions Learning HRA or identifying a colleague or nearby center where HRA is performed regularly is vital to the management of anal HSIL. Patients with SISCCA being considered for conservative management MUST HAVE HRA.
136 Conclusions If you are referring to a general, colorectal, or gynecologic oncologic surgeon; have a conversation with them about their specific training in HRA, if any. Standards of proficiency in HRA and possibly certification are desperately needed. Contact the International Anal Neoplasia Society for resources.
How might we implement screening for anal cancer in HIV-positive patients?
Objective How might we implement screening for anal cancer in HIV-positive patients? Identify the elements required to set up an anal cancer screening and prevention program J. Michael Berry, MD Associate
More informationHPV-related papillomatous-condylomatous lesions in female anogenital area
HPV-related papillomatous-condylomatous lesions in female anogenital area Theo Panoskaltsis MD, FRCOG, CCST (UK) Epidemiology Anal cancer is increasing in both men and women Groups at risk: - HIV (+)
More informationLABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
More informationTo further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy
1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous
More informationHIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco
Anal cytology and anal cancer in HIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco April 10, 2010 Disclosures Merck and Co: Research grant support, advisory boards
More informationCervical Dysplasia and HPV
Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk
More informationWOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0 / 0 / 6 ANY MISSING OR INCOMPLETE TEST RESULTS
More informationLABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
More informationIntroduction to Colposcopy
Introduction to Colposcopy Papanicolaou smear (Pap smear) screening test Colposcopy diagnostic test Introduction to Colposcopy Acetic acid and Lugol s iodine applied Cervix examined under magnification
More informationBecoming a colposcopist: Colposcope case studies
Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening
More informationVIN/VAIN O C T O B E R 3 RD J M O R G A N
VIN/VAIN O C T O B E R 3 RD 2 0 1 8 J M O R G A N Vaginal Intraepithelial Neoplasia VAIN I, II, III Incidence 0.1/100,000 women in US Mean age 50s (J Womens Health (Larchmt) 2009:18:1731) (J Obstet Gynaecol
More informationPRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
More informationDisclosures Teresa M Darragh, MD
Below the Belt: Screening for HPV-associated Cancers Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Disclosures Teresa M Darragh, MD Hologic: Research
More informationVulvar intraepithelial neoplasia: Current concepts
Vulvar intraepithelial neoplasia: Current concepts L. Stewart Massad, M.D. Dept. of Obstetrics & Gynecology Washington University School of Medicine St. Louis, MO Disclosure I have no financial ties to
More informationSTANDARDIZED PROCEDURE HIGH RESOLUTION ANOSCOPY (HRA) (Adults, Peds)
I. Definition High Resolution Anoscopy (HRA) is the visualization of the anus and perianusanal mucosa through a colposcope using acetic acid and Lugol s solutions. The purpose of HRA is to identify squamous
More informationShould Anal Pap Smears Be a Standard of Care in HIV Management?
Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV
More informationMEDICAL POLICY SUBJECT: HIGH RESOLUTION ANOSCOPY
MEDICAL POLICY SUBJECT: HIGH RESOLUTION ANOSCOPY PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationMEDICAL POLICY EFFECTIVE DATE: 12/20/12 REVISED DATE: 11/21/13, 10/16/14 SUBJECT: HIGH RESOLUTION ANOSCOPY
MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationUpdate on Anal HPV. Medical Management of AIDS. December 9, Joel Palefsky Department of Medicine University of California, San Francisco
Update on Anal HPV Medical Management of AIDS December 9, 2017 Joel Palefsky Department of Medicine University of California, San Francisco Disclosures Merck and Co- research and travel support Antiva
More informationColposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK
Colposcopic Principles Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK The cervix topics discussed are: original squamous epithelium endocervical epithelium
More informationManagement Algorithms for Abnormal Cervical Cytology and Colposcopy
Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent
More informationClinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary
Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in
More informationCERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix
More informationI have no financial interests to disclose.
Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests
More informationBenign anorectal diseases
Benign anorectal diseases Symptoms Bleeding Pruritus Discharge Fecal incontinence Diarrhea Constipation False need to defecate Examinations Clinical exam Anuscopy Rectosigmoidoscopy Endosonography MRI
More informationHCT Medical Policy. High-Resolution Anoscopy for Evaluation of Anal Lesions Policy # HCT109 Current Effective Date: 10/30/2014.
HCT Medical Policy High-Resolution Anoscopy for Evaluation of Anal Lesions Policy # HCT109 Current Effective Date: 10/30/2014 Medical Policies are developed by HealthyCT to assist in administering plan
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationWhat is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationGLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016
GLANDULAR LESIONS PITFALLS IN MANAGEMENT Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 Introduction Cervical glandular lesions are much less common than squamous lesion Incidence
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationCancer in the LGBTQ Community. Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine
+ Cancer in the LGBTQ Community Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine + Objectives Discuss the possible reasons that LGBTQ people have a disproportionate
More informationInformation about your HANS assessment, HPV and AIN
Information about your HANS assessment, HPV and AIN Incorporating hospital and community health services, teaching and research This booklet has been written for people attending the Homerton anal neoplasia
More information5. Colposcopist performing exam: (Draw SCJ, acetowhite, punctation, mosaics, atypical vessels, and other lesions)
Appendix 1 Colposcopy record 1. Medical Record Number: 2. Patient s Name: EXAMPLE 3. Age: 4. Date of visit: / / (Day/Month/Year) 5. Colposcopist performing exam: 6. Did you see the entire suamocolumnar
More informationNew Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology
New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.
More informationTreatment of High-Grade Anal Dysplasia. Ross D. Cranston MB ChB MD FRCP Fundació Lluita contra la Sida
Treatment of High-Grade Anal Dysplasia Ross D. Cranston MB ChB MD FRCP Fundació Lluita contra la Sida Context What is the problem? What are we doing about it? What are the ongoing issues? Incidence rate
More informationLABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14
LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.
More informationWOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16
WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 05/01/95 ANY MISSING OR INCOMPLETE TEST RESULTS
More informationSESSION J4. What's Next? Managing Abnormal PAPs in 2014
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines
More informationHPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series
HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%
More informationStreamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014
Streamlining Protocols-From Strategy to Implementation Doreen Ramogola-Masire Botswana UPenn Partnership 18-20 June 2014 Botswana-UPenn Partnership Partnership between Government of Botswana, University
More informationMEDICAL POLICY SUBJECT: HIGH RESOLUTION ANOSCOPY EFFECTIVE DATE: 12/20/12 REVISED DATE: 11/21/13, 10/16/14, 09/17/15, 9/15/16 ARCHIVED DATE: 09/21/17
MEDICAL POLICY SUBJECT: HIGH RESOLUTION ANOSCOPY PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationHPV From the Bottom Up
HPV From the Bottom Up Evolving Strategies for the Treatment & Prevention of Anal Disease Rebecca A. Levine, MD Assistant Professor of Surgery Colon & Rectal Surgery Montefiore Medical Center Einstein
More informationUnderstanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
More informationDysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationHPV infections and potential outcomes
CONTENTS Preface by Silvia de Sanjosé... 33 Preface by Jacob Bornstein... 37 Author s note... 39 Acknowledgments... 45 CHAPTER 1 HPV infections and potential outcomes HPV: What it is, where it is and what
More informationOver-diagnoses in Cytopathology: Is histology the gold standard?
Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationThe Anal Canal and Perianus: HPV-Related Disease
CHAPTER 17 TERESA M. DARRAGH J. MICHAEL BERRY NAOMI JAY JOEL M. PALEFSKY The Anal Canal and Perianus: HPV-Related Disease 17.1 EPIDEMIOLOGY OF ANAL HPV INFECTION, ANAL INTRAEPITHELIAL NEOPLASIA, AND ANAL
More informationCervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
More informationWhat Causes Cervical Cancer? Symptoms of Cervical Cancer
Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through
More informationInternational Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics Treatment of Cervical Precancerous Lesions using Thermocoagulation(Cold Coagulation) and Cryotherapy General Principles All high grade CIN should be
More informationCervical cancer control in developing countries
Cervical cancer control in developing countries Dr. Y. Vuhahula Tanzania WHO/GFMER/IAMANEH Postgraduate Training Course in Reproductive Health Geneva 2004 Magnitude of the problem Cervical cancer is the
More informationBottoms UP HIV and Anal Cancer from Screening to Prevention
Bottoms UP HIV and Anal Cancer from Screening to Prevention Paul MacPherson PhD, MD, FRCPC Associate Professor Division of Infectious Diseases University of Ottawa The New Reality Normal or near-normal
More informationHPV infection and intraepithelial lesions from the anal region: how to diagnose?
HPV infection and intraepithelial lesions from the anal region: how to diagnose? Review Article ABSTRACT In the last years, the prevalence of HPV infection in the anal region has increased, especially
More information1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
More informationCOLPOSCOPY Equipment and procedure
COLPOSCOPY Equipment and procedure Kunter Yüce M.D Professor and Head of Gynecologic Oncology Hacettepe University, Ankara, Turkey President of Turkish Society for Colposcopy and Cervical Pathology Member
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More informationThe Anal Canal: an Important Transition Zone for Rectal Microbicide Development
The Anal Canal: an Important Transition Zone for Rectal Microbicide Development Ross D. Cranston MD FRCP Assistant Professor University of Pittsburgh Plan Anal canal Comparison with the rectum Common anal
More informationManagement of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
More informationEFC and European Standards for Colposcopic Evaluation
EFC and European Standards for Colposcopic Evaluation Cagatay Taskiran, MD. Koc University School of Medicine, and VKF American Hospital Department of Obstetrics and Gynecology Division of Gynecologic
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationCytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
More informationTHE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES
THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES Denise Uyar, MD Associate Professor OB/GYN Chief Gynecologic Oncology Medical College of Wisconsin April 12, 2019 NO DISCLOSURES
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationUnderstand Your Results
Understand Your Results The Pap test takes little time and may save your life. This simple screening test checks for cell changes in the cervix, the opening of the uterus. If your Pap results were abnormal,
More informationUpdated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.
Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. 27 May, 2014 London, England Faculty Disclosure X No, nothing to disclose Yes, please specify
More informationThe society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationWorld Journal of Colorectal Surgery
World Journal of Colorectal Surgery Volume 6, Issue 5 2016 Article 1 High Resolution Anoscopy In A High Risk Population: A Retrospective Review Of 61 Patients Erich M. Wessel Mazin Al-Kasspooles Peter
More informationCervical Cancer : Pap smear
Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationObjectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies
Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives
More informationCervical Conization. 1
Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly
More informationCervical Precancer: Evaluation and Management
TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of
More informationTreatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?
Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this
More informationConflict of Interest Disclosure. Anita L. Nelson, MD. Principles Underlying Screening Recommendations. Learning Objectives
Advanced Colposcopy Conflict of Interest Disclosure Anita L. Nelson, MD Anita L. Nelson, MD Professor OB-GYN David Geffen School of Medicine at UCLA CFHC s 2014 Women s Health Update Berkeley, CA May 20,
More informationCervical Cancer Prevention Month. January 2011 Morehouse College
Cervical Cancer Prevention Month January 2011 Morehouse College What is Cervical Cancer? Cervical Cancer begins in the cervix (lower part of the womb, called the uterus). Cervical Cancer, at one point,
More informationAnale intraepitheliale Neoplasien (AIN) Workshop 2018
Anale intraepitheliale Neoplasien (AIN) Workshop 2018 Diagnostics, Follow-Up and Vaccination Gastroenterologie Kantonsspital St. Gallen Diagnostics Region of Interest The Tools High Resolution Anoscopy
More informationHuman Papillomavirus
Human Papillomavirus Dawn Palaszewski, MD Assistant Professor of Obstetrics and Gynecology University of February 18, 2018 9:40 am Dawn Palaszewski, MD Assistant Professor Department of Obstetrics and
More informationCervical Cancer Screening Guidelines Update
Frontier AIDS Education and Training Center Cervical Cancer Screening Guidelines Update Hillary Liss, MD Harborview Medical Center, Madison and Adult Medicine Clinics Frontier AETC, Medical Program Director
More informationCOLPOSCOPY MADE EASY AND SIMPLE
COLPOSCOPY MADE EASY AND SIMPLE Burton Brodsky M.D. Husband, father of four kids Chief of gynecology University of Toledo Assistant residency director University of Toledo Associate professor university
More informationHuman Papillomavirus (HPV) in Patients with HIV.
Human Papillomavirus (HPV) in Patients with HIV www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS residents with HIV who are screened for HPV-related dysplasia and managed effectively.
More informationCervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital
Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before
More informationHuman Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Human Papillomaviruses
More informationCINtec p16 INK4a Staining Atlas
CINtec p16 INK4a Staining Atlas Rating Rating Positive The rating positive will be assigned if the p16 INK4a -stained slide shows a continuous staining of cells of the basal and parabasal cell layers of
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationBCNprovidernews SEPTEMBER OCTOBER 2011 Medical Policy updates
The following applies to Blue Care Network members: Noncovered services appear first; covered services follow. The effective date is indicated for the service, technology or procedure. Noncovered services
More informationJean Anderson, MD Catherine Sewell, MD, MPH
Jean Anderson, MD Catherine Sewell, MD, MPH To review diagnosis and management of HPV disease in the setting of HIV infection and address controversies HIV-infected women have: higher prevalence and incidence
More informationASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests
ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests www.treatmentok.com Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Ann Arbor, Michigan Disclosures
More informationName of Policy: Speculoscopy
Name of Policy: Speculoscopy Policy #: 095 Latest Review Date: September 2011 Category: Medicine/OB Gyn Policy Grade: C Background/Definitions: As a general rule, benefits are payable under Blue Cross
More informationYour Colposcopy Visit
Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to
More informationchapter 4. The effect of oncogenic HPV on transformation zone epithelium
chapter 4. The effect of oncogenic HPV on transformation zone epithelium CHAPTER 1 All squamous cervical cancer (and probably all cervical adenocarcinoma) is associated with oncogenic HPV, and the absence
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationCervical Cancer Prevention in the 21 st Century Changing Paradigms
Cervical Cancer Prevention in the 21 st Century Changing Paradigms Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M.
More informationEvaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear
The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions
More information